Join to view full profile
41 Mall RdBurlington, MA 01805
Phone+1 781-744-5100
Fax+1 978-287-8955
Dr. Gee is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Lahey ClinicResidency, Urology, 1996 - 2000
Beth Israel Deaconess Medical CenterResidency, Surgery, 1994 - 1996
Harvard Medical SchoolClass of 1994
Certifications & Licensure
MA State Medical License 2009 - 2028
TX State Medical License 2002 - 2027
WI State Medical License 2003 - 2011
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Lahey Clinic’s Meaningful Use Reporting Tool, Lahey Clinic Foundation Inc, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active Surveillance Start of enrollment: 2014 May 08
- Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery Start of enrollment: 2014 Oct 01
Publications & Presentations
PubMed
- 3 citationsEndovascular Downstaging: A New Method for Managing Renal Cell Carcinoma Tumor Thrombus Invading the Inferior Vena Cava Above the Hepatic Veins (Level III) or into the...John A Libertino, Malik Ahmed, Thomas Piemonte, Jason Gee
Cancers. 2025-01-15 - 46 citationsA Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue BiomarkersJason R. Gee, Daniel Saltzstein, KyungMann Kim, Jill M. Kolesar, Wei Huang
Cancer Prevention Research. 2017-05-01 - 21 citationsMicroRNA Expression Profile Identifies High Grade, Non-Muscle-Invasive Bladder Tumors at Elevated Risk to Progress to an Invasive Phenotype.Sara M. Lenherr, Sheaumei Tsai, Brasil Silva Neto, Travis Sullivan, Cara B. Cimmino
Genes. 2017-02-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: